Division of Basic Medical Science, Department of Nursing, Meiho Institute of Technology, Ping Tung, Taiwan, ROC.
Neuroimmunomodulation. 2010;17(4):223-8. doi: 10.1159/000290038. Epub 2010 Mar 5.
The prognostic value of interleukin (IL)-10 in patients after acute ischemic stroke (IS) is not well understood. This study tested the hypothesis that serum levels of IL-10 are substantially increased after IS and predictive of IS outcome.
Serum IL-10 levels were examined 48 h after acute IS in 135 consecutive patients, and in 20 healthy and 30 at-risk controls.
Mean serum IL-10 was significantly higher in IS patients than in both control groups (p < 0.0001, respectively). Additionally, serum IL-10 was significantly higher in patients with severe neurological impairment [defined as a score >or=12 on the National Institute of Health Stroke Scale (NIHSS)] than in patients with less severe neurological impairment (NIHSS score <12) 48 h after IS (p < 0.0001). Furthermore, higher serum IL-10 was strongly and independently correlated with severe neurological impairment (NIHSS >or=12) 48 h after acute IS (p < 0.0001), and independently predictive of combined major adverse clinical outcomes (defined as recurrent IS, any cause of death or NIHSS >or=12) on day 90 following IS (p < 0.0001).
Serum IL-10 is an independent prognosticator of IS outcome.
白细胞介素(IL)-10 在急性缺血性脑卒中(IS)患者中的预后价值尚不清楚。本研究旨在验证血清 IL-10 水平在 IS 后显著升高并可预测 IS 结局的假设。
在 135 例连续急性 IS 患者和 20 例健康对照者及 30 例高危对照者中,检测了 48 小时后血清 IL-10 水平。
与两组对照组相比,IS 患者的平均血清 IL-10 水平显著升高(分别为 p < 0.0001)。此外,IS 后 48 小时,神经功能严重受损患者(定义为国立卫生研究院卒中量表(NIHSS)评分≥12)的血清 IL-10 显著高于神经功能损伤较轻的患者(NIHSS 评分 <12)(p < 0.0001)。此外,较高的血清 IL-10 与 IS 后 48 小时的严重神经功能损伤(NIHSS >or=12)强烈且独立相关(p < 0.0001),并且可独立预测 IS 后 90 天的联合主要不良临床结局(定义为复发 IS、任何原因死亡或 NIHSS >or=12)(p < 0.0001)。
血清 IL-10 是 IS 结局的独立预后指标。